Manufacture

The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?

AAV vectors are a promising tool for gene therapy and regenerative medicine, but only if they can be manufactured efficiently

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Sitting Down With... Keith Thompson, CEO of the Cell and Gene Therapy Catapult, UK.

Pharma suppliers are teaming up to take ready-to-use technology to the next level.

Can sophisticated (spectroscopic) sensors streamline bioprocess monitoring to better meet FDA standards?

Can sophisticated (spectroscopic) sensors streamline bioprocess monitoring to better meet FDA standards?

A choice of fumigants are available for fumigating microbiological safety cabinets and high-level containment rooms. One substance that is still used in the industry is formaldehyde, but given that formaldehyde is toxic, carcinogenic and corrosive, you’d be better looking for alternatives.

“Batch is best,” according to many in the industry, but when cost reductions and greater efficiencies are a priority, continuous processing is becoming increasingly compelling.